In-stent Flow Hemodynamics and the Risk of STent Failure Following Bioresorbable Vascular ScAFFolds Implantation – the STAFF Study

1. Cardiovascular diseases. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/Search in Google Scholar

2. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541-2619.Search in Google Scholar

3. Montone RA, Niccoli G, De Marco F et al. Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials. Circulation. 2017;135:2145-2154.10.1161/CIRCULATIONAHA.117.028479Search in Google Scholar

4. Felix CM, Vlachojannis GJ, IJsselmuiden AJJ, et al. Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. EuroIntervention. 2017;13:e177-e184.10.4244/EIJ-D-17-00119Search in Google Scholar

5. Pernigotti A, Moscarella E, Spitaleri G, Scardino C, Ishida K, Brugaletta S. Methods to assess bioresorbable vascular scaffold devices behaviour after implantation. J Thorac Dis. 2017;9:S959-S968.10.21037/jtd.2017.06.110Search in Google Scholar

6. Sato T, Tölg R, El-Mawardy M, Sulimov DS, Richardt G, Abdel-Wahab M. The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis. J Cardiol. 2017;pii:S0914-5087(17)30094-1.Search in Google Scholar

7. Duraiswamy N, Jayachandran B, Byrne J, Moore JE Jr, Schoephoerster RT. Spatial distribution of platelet deposition in stented arterial models under physiologic flow. Ann Biomed Eng. 2005;33:1767-1777.10.1007/s10439-005-7598-2Open DOISearch in Google Scholar

8. DePaola N, Gimbrone MA Jr, Davies PF, Dewey CF Jr. Vascular endothelium responds to fluid shear stress gradients. Arterioscler Thromb. 1992;12:1254-1257.10.1161/01.ATV.12.11.1254Search in Google Scholar

9. Nagel T, Resnick N, Dewey CF, Gimbrone MA Jr. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol. 1999;19:1825-1834.10.1161/01.ATV.19.8.1825Open DOISearch in Google Scholar

10. Davies PF, Polacek DC, Handen JS, Helmke BP, DePaola N. A spatial approach to transcriptional profiling: mechanotransduction and the focal origin of atherosclerosis. Trends Biotechnol. 1999;17:347-351.10.1016/S0167-7799(99)01348-7Search in Google Scholar

11. García-Cardeña G, Comander JI, Blackman BR, Anderson KR, Gimbrone MA. Mechanosensitive endothelial gene expression profiles: scripts for the role of hemodynamics in atherogenesis? Ann NY Acad Sci. 2001;947:1-6.Search in Google Scholar

12. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol. 2000;86:3J-8J.10.1016/S0002-9149(00)01339-4Search in Google Scholar

13. Folie BJ, McIntire LV. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. Biophys J. 1989;56:1121-1141.10.1016/S0006-3495(89)82760-2Search in Google Scholar

14. Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. JACC Cardiovasc Interv. 2013;6:999-1009.10.1016/j.jcin.2013.05.01724156961Search in Google Scholar